[HTML][HTML] Effects of cisplatin-loaded niosomal nanoparticleson BT-20 human breast carcinoma cells

L Kanaani, M Ebrahimifar, AA Khiyavi… - Asian Pacific journal of …, 2017 - ncbi.nlm.nih.gov
Breast cancer is the fifth most common cause of death among women worldwide.
Resistance to cisplatin is a main challenge in its treatment. Our present aim was to prepare …

Biomimetic hybrid scaffold containing niosomal deferoxamine promotes angiogenesis in full-thickness wounds

S Nour, R Imani, M Mehrabani, A Solouk… - Materials Today …, 2023 - Elsevier
Effective management of full-thickness wounds faces significant challenges due to poor
angiogenesis and impaired healing. Biomimetic tissue-engineered scaffolds with …

Capecitabine-loaded nanoniosomes and evaluation of anticancer efficacy

R Nazari-Vanani, K Karimian, N Azarpira… - Artificial cells …, 2019 - Taylor & Francis
Capecitabine (CAP) is an FDA-approved and frequently used chemotherapeutic agent for
the treatment of various cancers. However, there are some side effects and chemoresistance …

Preparation, characterization and cytotoxic studies of cisplatin-containing nanoliposomes on breast cancer cell lines

F Mohammadinezhad, A Talebi… - Asian Pacific Journal of …, 2023 - waocp.com
Objective: Today, cancer is one the most important challenges in modern medicine. Breast
carcinoma is one type of cancer that is treated with cisplatin, a chemotherapy drug. By using …

Development of new nanoniosome carriers for vorinostat: Evaluation of anticancer efficacy in vitro

R Nazari-Vanani, Z Kayani, K Karimian… - Journal of …, 2024 - Elsevier
Vorinostat (VST) is a chemotherapeutic agent administrated for various types of cancers.
However, it suffers from side effects and chemoresistance that reduce its application …

Synthesis of gamma radiation-induced PEGylated cisplatin for cancer treatment

MG Torres, JC Cortez, RBM Soto, AR Perez, H Pfeiffer… - RSC …, 2018 - pubs.rsc.org
The use of poly (ethylene glycol)(PEG) for the development of novel PEGylated
biomolecules is playing an increasingly meaningful role in cancer treatment. Cisplatin …

In vitro evaluation of lysyl oxidase antibody conjugated nanoparticles

MS Kim, SJ Park, BK Gu, HJ Shin, KH Lee… - Macromolecular …, 2016 - Springer
In this study, we prepared poly (lactic-co-glycolic acid)(PLGA) nanoparticles (NPs)
conjugated to lysyl oxidase-inhibiting antibodies (LOX ab) as an anticancer therapy in order …

[PDF][PDF] Preparation, characterization and cytotoxic studies of carboplatin-containing nanoniosome on ovarian cancer cell

L Kanaani, T Mehrdiba, M Chiani, Z Saffari… - 2016 - sid.ir
Carboplatin is chemotherapy drug that is used against some forms of cancer such as
ovarian carcinoma. The aim of this study is to improve the therapeutic efficacy of carboplatin …

Evaluation of Pegylated Nanoniosomal Cisplatin on Rat C6 in Vitro

M Babaei, MM Pour, S Shahbazian… - Journal of Current …, 2015 - search.proquest.com
Cisplatin is one of the most useful drugs in chemotherapy, which have several therapeutic
properties. Nevertheless, this drug carries some side effects. In order to reduce such effects …